Dr. Nicholas Casewell graduated from the University of Liverpool (BSc Tropical Disease Biology), during which time he also studied at the Alistair Reid Venom Research Unit at the Liverpool School of Tropical Medicine. Casewell gained a Ph.D. studentship at Bangor University where he studied the composition, evolution and immunology of saw-scaled viper venoms and their antivenoms with Dr. Wolfgang Wüster. The result of Dr. Casewell’s Ph.D. research saw him nominated as a finalist for the Society for Molecular Biology and Evolution’s young researcher prize, the Walter M. Fitch Award, in 2011. Subsequently, Casewell became Antivenom Manager for the UK manufacturing company MicroPharm Limited, in a commercial and academic collaboration with the Liverpool School of Tropical Medicine.  Since 2013, Dr. Casewell has worked in academia and has studied the evolution of various animal venom systems, including snakes, fish, cnidarians and mammals. In 2016, he was appointed as a Senior Lecturer in the Alistair Reid Venom Research Unit of the Liverpool School of Tropical Medicine and was awarded a Sir Henry Dale Research Fellowship by the Wellcome Trust and Royal Society. His research focuses on understanding variation in snake venom composition and using this information to generate new snakebite treatments.